Subscribe to Newsletter

James N. Thomas

The Power List 2020 – Biopharmaceuticals

EVP, Global Head of Biotherapeutics and President of US Operations at Just - Evotec Biologics

Over the course of his career, Thomas has contributed to the advancement of many important therapeutics including Activase, Vectibix, Enbrel, Prolia/Xgeva and Repatha, as well as numerous biosimilar programs. Thomas has built teams, departments and functions passionate about creating and using innovative technologies to meet the needs of patients. In 2014, he co-founded and became CEO of Just Biotherapeutics, with a focus on expanding global access to biologics, and is now continuing this journey at Just-Evotec Biologics.

What one thing do you think will improve the biopharma industry?

Take a long view by focusing on the health of a global population and not just markets with the highest apparent returns. We are living on one planet that connects all our lives together.

What are the defining moments of your career?

Realizing about 25 years ago that the work we do is not about achievement but about significance. 

On COVID-19?

I’m proud of how the industry is stepping up. Now it's time to deliver!

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine